Mostrar el registro sencillo del ítem

dc.contributorUniversitat Ramon Llull. Esade
dc.contributor.authorprovencio, mariano
dc.contributor.authorRomero Villela, Pamela Nicole
dc.contributor.authorTabernero, Josep
dc.contributor.authorVera, Ruth
dc.contributor.authorVicente Baz, David
dc.contributor.authorArraiza Armendáriz, Antonio
dc.contributor.authorCamps, Carlos
dc.contributor.authorFELIP, ENRIQUETA
dc.contributor.authorGarrido López, Pilar
dc.contributor.authorGaspar, Bernard
dc.contributor.authorLlombart Cussac, Antonio
dc.contributor.authorLópez González, A.
dc.contributor.authorMagallón Pedrera, Isabel
dc.contributor.authorIBANEZ DE CACERES, INMACULADA
dc.contributor.authorMartínez-Olmos, Francisco José
dc.contributor.authorMur, Carlos
dc.contributor.authorNavarro Ruiz, Andrés
dc.contributor.authorPastor del Campo, Aida
dc.contributor.authorPeiró, Manel
dc.contributor.authorPolo, J.
dc.contributor.authorRodríguez-Lescure, Á.
dc.date.accessioned2025-02-24T21:27:02Z
dc.date.available2025-02-24T21:27:02Z
dc.date.issued2022
dc.identifier.issn1699-048Xca
dc.identifier.urihttp://hdl.handle.net/20.500.14342/5012
dc.description.abstractPurpose: The increase in the prevalence "long-term cancer survivor” (LCS) patients is expected to increase the cost of LCS care. The aim of this study was to obtain information that would allow to optimise the current model of health management in Spain to adapt it to one of efficient LCS patient care. Methods: This qualitative study was carried out using Delphi methodology. An advisory committee defined the criteria for participation, select the panel of experts, prepare the questionnaire, interpret the results and draft the final report. Results: 232 people took part in the study (48 oncologists). Absolute consensus was reached in three of the proposed sections: oncological epidemiology, training of health professionals and ICT functions. Conclusion: The role of primary care in the clinical management of LCS patients needs to be upgraded, coordination with the oncologist and hospital care is essential. The funding model needs to be adapted to determine the funding conditions for new drugs and technologies.ca
dc.format.extent13 p.ca
dc.language.isoengca
dc.publisherSpringer-Verlag Italia s.r.l.ca
dc.relation.ispartofClinical and Translational Oncologyca
dc.rights© L'autor/aca
dc.rightsAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.otherLong cancer survivorca
dc.titleFuture care for long-term cancer survivors: towards a new modelca
dc.typeinfo:eu-repo/semantics/articleca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.termscapca
dc.identifier.doihttp://doi.org/10.1007/s12094-021-02696-5ca
dc.description.versioninfo:eu-repo/semantics/publishedVersionca


Ficheros en el ítem

 

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© L'autor/a
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by/4.0/
Compartir en TwitterCompartir en LinkedinCompartir en FacebookCompartir en TelegramCompartir en WhatsappImprimir